Propensity score matched analysis for the safety and effectiveness of remdesivir in COVID-19 patients with renal impairment

Propensity score matched analysis for the safety and effectiveness of remdesivir in COVID-19 patients with renal impairment

Abstract Backgrounds Remdesivir (RDV) is an antiviral agent approved for the treatment of coronavirus disease 2019 (COVID-19); however, is not recommended for patients with renal impairment. Due to limitations associated with prospective clinical trials, real-world data on the safety and efficacy of...

Full description

Bibliographic Details
Main Authors: Eunmi Yang, Han Zo Choi, Subin Kim, Dong Hyun Oh, Mi Young Ahn, Sinyoung Ham, Eunyoung Lee, Jaehyun Jeon, Min-Kyung Kim, Hee-Chang Jang, Sang-Won Park, Jae-Phil Choi
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Infectious Diseases
Subjects:
Remdesivir
COVID-19
Renal insufficiency
Propensity Score
Safety
Online Access:https://doi.org/10.1186/s12879-023-08859-9

Similar Items

Similar Items